Cart
sales@molnova.com
tiquizium
CAS No. 149755-23-7
tiquizium( —— )
Catalog No. M28946 CAS No. 149755-23-7
Tiquizium has effective Antimuscarinic effect, and causes significant bronchodilation in patients with chronic obstructive pulmonary disease.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 151 | In Stock |
|
| 5MG | 149 | In Stock |
|
| 10MG | 220 | In Stock |
|
| 25MG | 337 | In Stock |
|
| 50MG | 462 | In Stock |
|
| 100MG | 619 | In Stock |
|
| 200MG | 835 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Nametiquizium
-
NoteResearch use only, not for human use.
-
Brief DescriptionTiquizium has effective Antimuscarinic effect, and causes significant bronchodilation in patients with chronic obstructive pulmonary disease.
-
DescriptionTiquizium has effective Antimuscarinic effect, and causes significant bronchodilation in patients with chronic obstructive pulmonary disease.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetAChR
-
RecptorEAAT2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number149755-23-7
-
Formula Weight330.53
-
Molecular FormulaC19H24NS2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC[N+](CCCC1)(C2)[C@H]1CCC2=C(c1cccs1)c1cccs1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kortagere S, et al. Identification of Novel Allosteric Modulators of Glutamate Transporter EAAT2. ACS Chem Neurosci. 2018 Mar 21;9(3):522-534.
molnova catalog
related products
-
Nebracetam hydrochlo...
Nebracetam hydrochloride is an agonist nootropic M1-muscarinic. Nebracetam hydrochloride induces a rise of intracellular Ca2+ concentration.
-
GAT107
GAT107 is a novel and potent α7 nicotinic cholinergic receptor modifier agonist and modulator with anti-inflammatory activity that reverses injury perception in a mouse model of neuropathic pain.
-
Emraclidine
Emraclidine is a muscarinic M4 receptor positive allosteric modulator and can be used in neurological diseases studies.
